UB Paderborn / Katalog / Suche / in CDI

Bile acid quantification of 20 plasma metabolites identifies lithocholic acid as a putative biomarker in Alzheimer’s disease

Metabolomics, 2018-01, Vol.14 (1), p.1-10, Article 1

2018

Link zum Volltext

Verfügbarkeit prüfen

Severity of Depression Impacts Imminent Conversion from Mild Cognitive Impairment to Alzheimer's Disease

Journal of Alzheimer's disease, 2017-01, Vol.59 (4), p.1439

2017

Link zum Volltext

Verfügbarkeit prüfen

How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes

Aging cell, 2004-08, Vol.3 (4), p.169-176

2004

Link zum Volltext

Verfügbarkeit prüfen

Interaction of ω-3 fatty acids with B vitamins in slowing the progression of brain atrophy: identifying the elderly at risk

The American journal of clinical nutrition, 2015-07, Vol.102 (1), p.7-8

Blasko, Imrich

2015

Link zum Volltext

Verfügbarkeit prüfen

Plasma Amyloid Beta-42 Independently Predicts Both Late-Onset Depression and Alzheimer Disease

The American journal of geriatric psychiatry, 2010-11, Vol.18 (11), p.973-982

2010

Link zum Volltext

Verfügbarkeit prüfen

Ibuprofen Decreases Cytokine-Induced Amyloid Beta Production in Neuronal Cells

Neurobiology of disease, 2001-12, Vol.8 (6), p.1094-1101

2001

Link zum Volltext

Verfügbarkeit prüfen

Plasma phosphatidylcholines and vitamin B12/folate levels are possible prognostic biomarkers for progression of Alzheimer's disease

Experimental gerontology, 2021-05, Vol.147, p.111264-111264, Article 111264

2021

Link zum Volltext

Verfügbarkeit prüfen

Use of Benzodiazepines in Alzheimer’s Disease: A Systematic Review of Literature

The international journal of neuropsychopharmacology, 2015-09, Vol.18 (10), p.pyv055-pyv055

2015

Link zum Volltext

Verfügbarkeit prüfen

Analysis of Cerebrospinal Fluid of Alzheimer Patients

Pharmacology, 2008-01, Vol.82 (3), p.214-220

2008

Link zum Volltext

Verfügbarkeit prüfen

Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: Prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine

Neurobiology of aging, 2008-01, Vol.29 (1), p.1-11

2008

Link zum Volltext

Verfügbarkeit prüfen

Conversion from mild cognitive impairment to dementia: Influence of folic acid and vitamin B12 use in the vita cohort

The Journal of nutrition, health & aging, 2012-08, Vol.16 (8), p.687-694

2012

Link zum Volltext

Verfügbarkeit prüfen

Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias

Dementia and geriatric cognitive disorders, 2006-01, Vol.21 (1), p.9

2006

Link zum Volltext

Verfügbarkeit prüfen

Lack of Antibody Production Following Immunization in Old Age: Association with CD8+CD28- T Cell Clonal Expansions and an Imbalance in the Production of Th1 and Th2 Cytokines

The Journal of immunology (1950), 2002-06, Vol.168 (11), p.5893-5899

2002

Link zum Volltext

Verfügbarkeit prüfen

Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer's disease

Drugs & aging, 2003, Vol.20 (2), p.101-113

2003

Link zum Volltext

Verfügbarkeit prüfen

Treatment patterns in inpatients with bipolar disorder at a psychiatric university hospital over a 9-year period: focus on mood stabilizers

International clinical psychopharmacology, 2012-09, Vol.27 (5), p.256

2012

Link zum Volltext

Verfügbarkeit prüfen

Cognitive deterioration in Alzheimer’s disease is accompanied by increase of plasma neopterin

Journal of psychiatric research, 2007-10, Vol.41 (8), p.694-701

2007

Link zum Volltext

Verfügbarkeit prüfen

Impfung gegen Alzheimer?

Wiener Klinische Wochenschrift, 2003-05, Vol.115 (9), p.279-280

2003

Link zum Volltext

Verfügbarkeit prüfen

Prospective study on association between plasma amyloid beta-42 and atherosclerotic risk factors

Journal of Neural Transmission, 2011-05, Vol.118 (5), p.663-672

2011

Link zum Volltext

Verfügbarkeit prüfen

Vaccination against Alzheimer disease?

Wiener Klinische Wochenschrift, 2003-05, Vol.115 (9), p.279-280

2003

Link zum Volltext

Verfügbarkeit prüfen

Diseases of aging

Vaccine, 2000-02, Vol.18 (16), p.1567-1583

2000

Link zum Volltext

Verfügbarkeit prüfen

Plasma amyloid β protein 42 in non-demented persons aged 75 years: Effects of concomitant medication and medial temporal lobe atrophy

Neurobiology of aging, 2005-08, Vol.26 (8), p.1135-1143

2005

Link zum Volltext

Verfügbarkeit prüfen

Effects of medications on plasma amyloid beta (Aβ) 42: Longitudinal data from the VITA cohort

Journal of psychiatric research, 2008-09, Vol.42 (11), p.946-955

2008

Link zum Volltext

Verfügbarkeit prüfen

Analysis of cerebrospinal fluid of Alzheimer patients. Biomarkers and toxic properties

Pharmacology, 2008, Vol.82 (3), p.214

2008

Link zum Volltext

Verfügbarkeit prüfen

P3‐121: Longitudinal study on plasma amyloid beta (Aβ) 42 and late‐onset depression: Concept of amyloid‐associated depression weakened

Alzheimer's & dementia, 2009-07, Vol.5 (4S_Part_12), p.P380-P380

2009

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal study on plasma amyloid beta (Aβ) 42 and late-onset depression: Concept of amyloid-associated depression weakened

Alzheimer's & dementia, 2009-07, Vol.5 (4), p.P380-P380

2009

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Bile acid quantification of 20 plasma metabolites identifies lithocholic acid as a putative biomarker in Alzheimer’s disease

Severity of Depression Impacts Imminent Conversion from Mild Cognitive Impairment to Alzheimer's Disease

How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes

Interaction of ω-3 fatty acids with B vitamins in slowing the progression of brain atrophy: identifying the elderly at risk

Plasma Amyloid Beta-42 Independently Predicts Both Late-Onset Depression and Alzheimer Disease

Ibuprofen Decreases Cytokine-Induced Amyloid Beta Production in Neuronal Cells

Plasma phosphatidylcholines and vitamin B12/folate levels are possible prognostic biomarkers for progression of Alzheimer's disease

Use of Benzodiazepines in Alzheimer’s Disease: A Systematic Review of Literature

Analysis of Cerebrospinal Fluid of Alzheimer Patients

Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: Prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine

Conversion from mild cognitive impairment to dementia: Influence of folic acid and vitamin B12 use in the vita cohort

Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias

Lack of Antibody Production Following Immunization in Old Age: Association with CD8+CD28- T Cell Clonal Expansions and an Imbalance in the Production of Th1 and Th2 Cytokines

Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer's disease

Treatment patterns in inpatients with bipolar disorder at a psychiatric university hospital over a 9-year period: focus on mood stabilizers

Cognitive deterioration in Alzheimer’s disease is accompanied by increase of plasma neopterin

Impfung gegen Alzheimer?

Prospective study on association between plasma amyloid beta-42 and atherosclerotic risk factors

Vaccination against Alzheimer disease?

Diseases of aging

Plasma amyloid β protein 42 in non-demented persons aged 75 years: Effects of concomitant medication and medial temporal lobe atrophy

Effects of medications on plasma amyloid beta (Aβ) 42: Longitudinal data from the VITA cohort

Analysis of cerebrospinal fluid of Alzheimer patients. Biomarkers and toxic properties

P3‐121: Longitudinal study on plasma amyloid beta (Aβ) 42 and late‐onset depression: Concept of amyloid‐associated depression weakened

Longitudinal study on plasma amyloid beta (Aβ) 42 and late-onset depression: Concept of amyloid-associated depression weakened

Suchergebnisse filtern